matically reduces ulcer relapse rates. The few studies lower relapse rates of duodenal and gastric ulcers after in patients with gastric ulcers had similar findings.
2, [25] [26] [27] [28] [29] successful Helicobacter pylori eradication. The aim of
Only a few studies have followed up on patients with this study was to determine the long-term outcome duodenal ulcers for more than 1 year. 30, 31 All these studof ulcer disease after successful H. pylori eradication.
ies report ulcer relapses (3%-22%) despite successful H. 
Study Population
Follow-up scheme. After complete healing of the ul- mand use was allowed), and successful H. pylori eradication, all patients were followed up by endoscopy at 3-month intervals for the first year. All patients were instructed to contact undergo repeated elective follow-up endoscopies with biopsies the responsible physician if dyspeptic symptoms recurred, and were followed up for a prolonged period. Patients were exthese patients were permitted to resume taking H 2 RA until cluded if they were on maintenance acid-suppressive therapy endoscopy was performed (within 2 days). or if they used aspirin or NSAIDs. Patients were excluded
After the first year, elective follow-up endoscopies were if they had undergone previous gastric surgery; were alcohol performed half-yearly in those patients willing to undergo abusers; had cardiac, pulmonary, liver, or kidney disease; or these sequential examinations. The remaining patients were were on anticoagulant therapy.
contacted again in 1995 to assess symptom recurrence and were asked to undergo one elective follow-up endoscopy. The
H. pylori Assessment
follow-up period lasted until the end of the study in 1995. H. pylori assessment was performed before and 4-6 weeks after completion of each H. pylori eradication attempt
Definition of Ulcer Recurrence
and at all endoscopies performed during follow-up. Four gasPeptic ulcer relapse was defined as endoscopically contric antrum biopsy specimens were routinely taken for culture firmed recurrent peptic ulcer after endoscopically proven heal-(n Å 2) and histopathology (n Å 2). Corpus biopsy specimens ing of the initial ulcer. By definition, superficial erosions were for culture (n Å 2) and histopathology (n Å 2) were taken not considered to be ulcers. when proton pump inhibitors became part of therapy.
Formalin-fixed gastric biopsy specimens were stained with 
Administered Therapies
Once an active ulcer was diagnosed, acid-suppressive therapy was administered until the ulcer was completely healed as confirmed by endoscopy. After complete ulcer healing, acidsuppressive therapy was discontinued, and H 2 RA was used only on demand.
After documented ulcer healing, an H. pylori eradication pared with 2% of the cured patients. 2,3 Only two studies have followed up on patients after healing of duodenal or gastric ulcer for a prolonged period. 30 ,31 Forbes et al. 30 after documented ulcer healing. Demographic characterreported on follow-up for 7 years (mean, 6.5 years; range, istics and clinical outcome are summarized in Table 1. 5.1-7.6 years), but 37% of their patients were lost before After the first year of follow-up, 96 patients (64 with final follow-up endoscopy. The duodenal ulcer relapse duodenal ulcers and 32 with gastric ulcers) remained rate in H. pylori-positive patients was 20% compared available for scheduled half-yearly endoscopies. The rewith 3% in H. pylori-negative patients. Interpretation maining 89 patients (74 with duodenal ulcers and 15 of the relapse rates, however, is hampered by the fact with gastric ulcers) who declined repetitive elective folthat H. pylori was assessed by ''clearance'' and not ''eradilow-up endoscopy were monitored for recurring sympcation'' of H. pylori. toms and received requests for follow-up endoscopy in For 4 years Labenz et al. 31 followed up on 190 patients 1995. Sixty-one of them underwent follow-up endoscopy with duodenal ulcers after H. pylori eradication by annual in 1995, whereas 28 (24 with duodenal ulcers and 4 endoscopy, or when patients were symptomatic, and with gastric ulcers) refused to do so. These 28 patients found a mean annual duodenal ulcer relapse rate of 0.9% had documented cure of the infection at the end of the per patient-year and concomitant reinfection after sucfirst year of follow-up after successful H. pylori eradication cessful eradication of H. pylori. Because no DNA fingerand had no recurrent symptoms through the end of folprinting of the isolated H. pylori strains was performed, low-up.
it remains speculative whether these recurrent infections Outcomes of patients with duodenal ulcers. H. were due to a new H. pylori infection or recrudescence. pylori eradication was successful in 141 of 183 patients
The incidence of apparent new infections, however, is with duodenal ulcer disease. None had a duodenal ulcer higher compared with the natural acquisition rate of the relapse. The median follow-up period after successful H. infection, which is reported to be approximately 0.3% pylori eradication in these patients was 2.6 years, ranging in the Western world. 33 This indicates the possibility of from 0.6 to 9.2 years, corresponding to 367 patientrecrudescence rather than reinfection. Moreover, Bell and years.
Powell's study indicates that the majority of H. pylori Outcomes of patients with gastric ulcers. H. pyreinfections occur in the first 12 months of follow-up lori eradication was successful in 45 of 64 patients with after apparent H. pylori eradication, a period in which gastric ulcer disease. None had a recurrent gastric ulcer.
recrudescence is to be expected. 34 In our study, duodenal The median H. pylori-negative follow-up period in these as well as gastric ulcer relapses did not occur in the H. patients was 2.5 years, ranging from 0.5 to 9.8 years, pylori-eradicated patients even after follow-up for up to corresponding to 113 patient-years.
9.8 years. We did not observe reinfection in any of these patients. The absence of recurrence of H. pylori infection Discussion after apparent successful eradication is in agreement with the results of our reinfection study, which includes a This is the first prospective long-term study showsubstantial number of nonulcer patients. 35 Reoccurrence ing complete absence of relapse of duodenal or gastric ulcers after successful eradication of H. pylori for a maxiof H. pylori infection was proved in 9 of 173 cured pa-/ 5E21$$0004 09-16-97 18:25:00 gasa WBS-Gastro tients. Two patients had an iatrogenically transmitted Interpretation of ulcer-relapse data is even more diffireinfection with H. pylori, as classified by DNA analysis cult for studies reporting on ulcer recurrence without of pre-eradication and posteradication strains. Recrudesrelating to the current H. pylori status. 18, 22, 23 Furthercence of H. pylori infection was likely in 6 of 7 patients more, patients should only be included in ulcer-relapse (identical DNA pattern pre-eradication and posteradicafollow-up studies after endoscopic proof of healing of the tion). Reoccurrence of H. pylori infection in 1 patient initial ulcer. Patients with inactive ulcer 16 or functional could not be classified because the pre-eradication strain dyspepsia 10 should be excluded. was lost.
Nevertheless, studies performed with appropriate diAll the patients with reoccurrence of H. pylori infection agnostic accuracy still report H. pylori-negative ulcer had functional dyspepsia at study entry, and no ulcer relapses. 6 -8,11,12,18,22,25,27,29,31 In these cases, the (occult) was noticed by repeated endoscopies during follow-up.
use of aspirin or NSAIDs may account for recurrent ulcers It is obvious that persistent or recrudescent H. pylori in the absence of H. pylori infection. 34 A recent review 3 infection, despite attempted H. pylori eradication, is acreported that NSAID use has been excluded in only one companied by recurrence of initially healed ulcers (data study. 20 The exclusion of patients using NSAIDs or aspinot shown). Studies of relapse rates of duodenal or gastric rin is probably the other important reason for the comulcers are complicated by several additional possible conplete absence of ulcer relapses in our study. founders. The loss of patients and the sometimes retroPublished studies on gastric ulcer relapse are scarce, spective character may lead to patient selection bias. 3 and the follow-up periods do not exceed 12 months. [25] [26] [27] [28] [29] Because H. pylori infection is associated with ulcer disIn our study, patients with gastric ulcers were followed ease, the ulcer relapses will also be related to recurrent for up to 9.8 years after H. pylori eradication. The infection.
1,10 It is therefore crucial that H. pylori eradicadifference in outcome on ulcer relapse rates between tion is documented accurately. Most of the studies report our study and other published studies is probably ulcer relapse rates (1%-22%) despite the apparent abmainly related to the fact that we vigorously excluded sence of H. pylori infection after eradication therapy.
5-31
patients on NSAID or aspirin therapy. If, after excluHowever, in several of these studies, it is obvious that sion of these confounders, H. pylori -negative duodenal ''clearance'' of H. pylori infection rather than ''eradicaor gastric ulcers remain, other rare causes, such as tion'' was used to assess cure of the infection. These
Crohn's disease and Zollinger -Ellison syndrome, studies report, as expected, higher ulcer relapse rates should be excluded. 36 -38 during presumed ''H. pylori-negative'' follow-up, rangIn conclusion, relapses of duodenal or gastric ulcers ing from 3% to 22%. 5, 9, 12, 21, 30 remain absent after true eradication of H. pylori, even Our study outcome contrasts with those of the aforeafter follow-up of up to 9.8 years. Eradication of H. mentioned studies, with the difference probably caused pylori should therefore become mandatory treatment by the assessment of cure of H. pylori infection underfor both duodenal and gastric ulcer disease. Ulcer distaken at least 4 weeks after the cessation of H. pylori ease that has been lifelong and recurrent, possibly aceradication therapy using two different methods (culture companied by potentially life-threatening complicaand histology). 
